Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis

Lupus

Volumn 18, Issue 1, 2009, Pages 22-28

  Kang, E H ^a   Moon, K C ^a   Lee, E Y ^a   Lee, Y J ^a   Lee, E B ^a   Ahn, C ^a   Song, Y W ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Galectin 3; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA; GALECTIN 3;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETICS; GLOMERULUS; HUMAN; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; METABOLISM; PATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; COMPLEMENT C3; COMPLEMENT C4; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALECTIN 3; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; YOUNG ADULT;

EID: 62749106846     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203308094361     Document Type: Article

References (35)

1. Barondes, SH, Cooper, DN, Gitt, MA, Leffler, H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807-20810.
2. Dumic, J, Dabelic, S, Flogel, M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006; 1760: 616-635.
3. Hsu, DK, Zuberi, RI, Liu, FT. Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J Biol Chem 1992; 267: 14167-14174.
4. Menon, RP, Hughes, RC. Determinants in the N-terminal domains of galectin-3 for secretion by a novel pathway circumventing the endoplasmic reticulum-Golgi complex. Eur J Biochem 1999; 264: 569-576.
5. Barboni, EA, Bawumia, S, Henrick, K, Hughes, RC. Molecular modeling and mutagenesis studies of the N-terminal domains of galectin-3: evidence for participation with the C-terminal carbohydrate recognition domain in oligosaccharide binding. Glycobiology 2000; 10: 1201-1208.
6. van den Brule, F, Califice, S, Castronovo, V. Expression of galectins in cancer: a critical review. Glycoconj J 2004; 19: 537-542.
7. Dagher, SF, Wang, JL, Patterson, RJ. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A 1995; 92: 1213-1217.
8. Yang, RY, Hsu, DK, Liu, FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 1996; 93: 6737-6742.
9. Fukumori, T, Takenaka, Y, Oka, N, et al. Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res 2004; 64: 3376-3379.
10. Liu, L, Sakai, T, Sano, N, Fukui, K. Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling. Biochem J 2004; 380: 31-41.
11. Inohara, H, Raz, A. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 1995; 55: 3267-3271.
12. Swarte, VV, Mebius, RE, Joziasse, DH, Van den Eijnden, DH, Kraal, G. Lymphocyte triggering via L-selectin leads to enhanced galectin-3-mediated binding to dendritic cells. Eur J Immunol 1998; 28: 2864-2871.
13. Ochieng, J, Leite-Browning, ML, Warfield, P. Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun 1998; 246: 788-791.
14. Jeng, KC, Frigeri, LG, Liu, FT. An endogenous lectin, galectin-3 (epsilon BP/Mac-2), potentiates IL-1 production by human monocytes. Immunol Lett 1994; 42: 113-116.
15. Sano, H, Hsu, DK, Yu, L, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 2000; 165: 2156-2164.
16. Nieminen, J, St-Pierre, C, Sato, S. Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses. J Leukoc Biol 2005; 78: 1127-1135.
17. Frigeri, LG, Zuberi, RI, Liu, FT. Epsilon, BP, a beta-galactosidebinding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells. Biochemistry 1993; 32: 7644-7649.
18. Dong, S, Hughes, RC. Galectin-3 stimulates uptake of extracellular Ca2+ in human Jurkat T-cells. FEBS Lett 1996; 395: 165-169.
19. Ohshima, S, Kuchen, S, Seemayer, CA, et al. Galectin-3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 2003; 48: 788-795.
20. Lee, YJ, Kang, SW, Song, JK, et al. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity. Clin Exp Rheumatol 2007; 25(Suppl. 45): S41-S45.
21. Lim, Y, Lee, DY, Lee, S, et al. Identification of autoantibodies associated with systemic lupus erythematosus. Biochem Biophys Res Commun 2002; 295: 119-124.
22. Hochberg, MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
23. Churg, J, Sobin, LH. Renal Disease: Classification and Atlas of Glomerular Disease. Igaku-Shoin: Tokyo; 1982.
24. Austin, HA, Muenz, LR, Joyce, KM, Antonovych, TT, Balow, JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689-695.
25. Kikuchi, Y, Kobayashi, S, Hemmi, N, et al. Galectin-3-positive cell infiltration in human diabetic nephropathy. Nephrol Dial Transplant 2004; 19: 602-607.
26. Hsu, DK, Yang, RY, Pan, Z, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000; 156: 1073-1083.
27. Sano, H, Hsu, DK, Apgar, JR, et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003; 112: 389-397.
28. Sasaki, S, Bao, Q, Hughes, RC. Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies. J Pathol 1999; 187: 481-489.
29. Kasper, M, Hughes, RC. Immunocytochemical evidence for a modulation of galectin 3 (Mac-2), a carbohydrate binding protein, in pulmonary fibrosis. J Pathol 1996; 179: 309-316.
30. Lippert, E, Falk, W, Bataille, F, et al. Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor. Gut 2007; 56: 43-51.
31. Henderson, NC, Mackinnon, AC, Farnworth, SL, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A 2006; 103: 5060-5065.
32. Goumenos, D, Tsomi, K, Iatrou, C, et al. Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 1998; 13: 1652-1661.
33. Boukhalfa, G, Desmouliere, A, Rondeau, E, Gabbiani, G, Sraer, JD. Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp Nephrol 1996; 4: 241-247.
34. Goumenos, DS, Tsamandas, AC, Oldroyd, S, et al. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron 2001; 87: 240-248.
35. Holzman, LB, Wiggins, RC. Consequences of glomerular injury. Glomerular crescent formation. Semin Nephrol 1991; 11: 346-353.